Wexford Science & Technology
Wexford Science & Technology, LLC specializes in real estate strategies and solutions tailored for universities, academic medical centers, and research institutions. The company collaborates closely with its partner institutions to design and develop dynamic, mixed-use communities that promote research, discovery, and entrepreneurship. Wexford's services encompass construction, development planning, marketing, leasing, asset management, and financial investment for various real estate projects, all aimed at fostering vibrant environments conducive to innovation and collaboration.
Top Regions
Top Stages
3 past transactions
3Daughters
Seed Round in 2024
3Daughters is a women's healthcare company focused on advancing contraceptive methods through the development of a novel intrauterine device (IUD). This innovative, nonhormonal, frameless device incorporates three small elliptical magnetic units, providing a significant upgrade from traditional T-shaped IUDs that are often associated with pain, perforation, and expulsion during insertion. By addressing these common issues, 3Daughters aims to enhance the overall experience for female patients, offering them improved access to effective and comfortable contraceptive options.
3Daughters
Seed Round in 2024
3Daughters is a women's healthcare company focused on advancing contraceptive methods through the development of a novel intrauterine device (IUD). This innovative, nonhormonal, frameless device incorporates three small elliptical magnetic units, providing a significant upgrade from traditional T-shaped IUDs that are often associated with pain, perforation, and expulsion during insertion. By addressing these common issues, 3Daughters aims to enhance the overall experience for female patients, offering them improved access to effective and comfortable contraceptive options.
Previse
Seed Round in 2023
Capsulomics, LLC is a biotechnology company focused on developing and manufacturing DNA tests for the early detection of upper gastrointestinal (GI) cancers, particularly esophageal cancer and its precancerous condition, Barrett’s esophagus. Founded in 2018 and based in Halethorpe, Maryland, Capsulomics aims to address the diagnostic and prognostic uncertainties associated with GI diseases. By providing advanced diagnostic solutions, the company enables healthcare professionals to prevent, detect, and treat these conditions more effectively, ultimately enhancing patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.